Age-dependent Attenuation of Spatial Memory Deficits by the Histone Acetyltransferase P300/CBP-associated Factor (PCAF) in 3xTG Alzheimer's Disease Mice
Authors
Affiliations
Histone acetylation, catalyzed by histone acetyltransferases, has emerged as a promising therapeutic strategy in Alzheimer's disease (AD). By longitudinally characterizing spatial memory at 3, 6, and 9 mo of age, we show that acute activation and inhibition of the histone acetyltransferase PCAF remediated memory impairments in 3xTG-AD mice in an age-related bidirectional manner. At 3 and 6 mo of age, PCAF activation ameliorated memory deficits. At 9 mo of age, PCAF activation had no effect on spatial memory, whereas PCAF inhibition improved memory deficits in females. This work reveals a complex potential therapeutic role for PCAF in AD, initially benefitting memory but becoming detrimental as the disease progresses.
Multi-faceted regulation of CREB family transcription factors.
Chowdhury M, Haq M, Lee J, Jeong S Front Mol Neurosci. 2024; 17:1408949.
PMID: 39165717 PMC: 11333461. DOI: 10.3389/fnmol.2024.1408949.
Mitchnick K, Nicholson K, Wideman C, Jardine K, Jamieson-Williams R, Creighton S J Neurosci. 2024; 44(36).
PMID: 39138001 PMC: 11376336. DOI: 10.1523/JNEUROSCI.1574-23.2024.
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
De Plano L, Saitta A, Oddo S, Caccamo A Cells. 2024; 13(8.
PMID: 38667333 PMC: 11049073. DOI: 10.3390/cells13080719.
Basavarajappa B, Subbanna S Epigenomics. 2024; 16(5):331-358.
PMID: 38321930 PMC: 10910622. DOI: 10.2217/epi-2023-0428.
Pavlou S, Foskolou S, Patikas N, Field S, Papachristou E, Santos C Sci Rep. 2023; 13(1):3934.
PMID: 36894612 PMC: 9998435. DOI: 10.1038/s41598-023-31141-6.